Literature DB >> 7530597

A case-control study of nonrandom distribution of bleomycin-induced chromatid breaks in lymphocytes of lung cancer cases.

X Wu1, T C Hsu, J F Annegers, C I Amos, J J Fueger, M R Spitz.   

Abstract

We used a case-control study design to determine the association between bleomycin-induced chromatid breaks and the risk of lung cancer in general and by specific histopathological types. Lymphocytes from primary blood cultures of 78 controls and 75 cases with 4 histopathological types of lung cancer were treated with 0.03 unit/ml bleomycin for 5 h, and the frequency of induced chromatid breakage and the locations of the breaks were determined in Q-banded preparations. After adjustment for their length, the larger chromosomes had more breaks than the smaller chromosomes in both cases and controls. The cases had significantly more breaks on chromosomes 4 and 5 than the controls did, with odds ratios (ORs) of 4.9 [95% confidence limits (CL), 2.0, 11.7] and 3.9 (95% CL, 1.6, 9.3), respectively. When the lung cancers were classified by histopathological type, adenocarcinomas had significantly more breaks on chromosomes 4 and 5, with ORs of 3.0 (95% CL, 1.0, 8.7) and 3.5 (95% CL, 1.2, 10.7), respectively. For squamous cell carcinoma, the ORs were significantly elevated for breaks on chromosomes 2, 4, and 5 with ORs of 3.5 (95% CL, 1.0, 11.7), 10.2 (95% CL, 2.5, 41.9), and 7.9 (95% CL, 1.9, 32.8). For small cell carcinoma, breaks on chromosomes 2 and 4 showed significantly increased ORs of 33.2 (95% CL, 2.2, 513.3) and 20.4 (95% CL, 1.7, 250.1), respectively. However, no specific chromatid breaks were detected in cases with large cell carcinoma. When the frequency of chromatid breaks at specific regions was calculated, breaks at 4p14, 4q27, 4q31, 5q21-q22, 5q31, and 5q33 were significantly more common in lung cancer cases than in controls. Lung cancer risk had a dose-response relationship with breaks on chromosomes 4 and 5. Cigarette smoking had a strong interaction with breaks on chromosomes 2, 4, and 5. The findings suggest that the susceptibility of particular chromosome loci to mutagenic damage may be a risk factor for specific types of lung cancer.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7530597

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  Mutagen sensitivity and p53 expression in colorectal cancer in China.

Authors:  L Shao; M Lai; Q Huang
Journal:  Postgrad Med J       Date:  2001-11       Impact factor: 2.401

Review 2.  Using biomarkers of genetic susceptibility to enhance the study of cancer etiology.

Authors:  N Rothman; R B Hayes
Journal:  Environ Health Perspect       Date:  1995-11       Impact factor: 9.031

3.  The influence of the pituitary tumor transforming gene-1 (PTTG-1) on survival of patients with small cell lung cancer and non-small cell lung cancer.

Authors:  Nina Rehfeld; Helene Geddert; Ulrich-Peter Rohr; Abedelsalam Atamna; Astrid Rohrbeck; Guillermo Garcia; Slawek Kliszewski; Judith Neukirchen; Ingmar Bruns; Ulrich Steidl; Roland Fenk; Helmut E Gabbert; Ralf Kronenwett; Rainer Haas
Journal:  J Carcinog       Date:  2006-01-20

4.  Associations among telomerase activity, p53 protein overexpression, and genetic instability in lung cancer.

Authors:  X Wu; B Kemp; C I Amos; S E Honn; W Zhang; G L Walsh; M R Spitz
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.